IGHG3 and Guillain-Barre syndrome: In a former study, we could detect anti-CNTN1 IgG3 in two patients with inflammatory neuropathy, both tested during the acute onset of disease [12] and anti-Caspr IgG3 in a patient with GBS phenotype [5].